Originally published on Mon March 25, 2013 9:49 am
The calendar says one thing, but the snow, slush and ice coating the nation from the Central Rockies through parts of the Midwest and on into the mid-Atlantic and Northeast say something else entirely.
The U.S. Supreme Court hears arguments Monday in a case worth billions of dollars to pharmaceutical companies and American consumers. The issue is whether brand-name drug manufacturers may pay generic drug manufacturers to keep generics off the market. These payments — a form of settlement in patent litigation — began to blossom about a decade ago when the courts, for the first time, appeared to bless them.